2021
DOI: 10.1002/jssc.202100639
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a liquid chromatography‐tandem mass spectrometry method with triple‐stage fragmentation to determine levetiracetam in epileptic patient serum and its application in therapeutic drug monitoring

Abstract: Levetiracetam is an antiepileptic drug that is primarily approved by the Food and Drug Administration for the treatment of focal and generalized seizures. This study describes the development and validation of a highly selective and sensitive liquid chromatography‐tandem mass spectrometry method with triple‐stage fragmentation to determine levetiracetam in epileptic patient serum. After simple protein precipitation, the analytes were separated on a short reversed‐phase column (Agilent Poroshell 120 SB‐C18 colu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…Targeted metabolomics was performed as previously reported [ 28 , 29 ]. For sample preparation for quality control (QC) and isotope internal (IS) standards, nine metabolite standards and the IS were dissolved with 90% acetonitrile to a final concentration of 1 mg/mL.…”
Section: Methodsmentioning
confidence: 99%
“…Targeted metabolomics was performed as previously reported [ 28 , 29 ]. For sample preparation for quality control (QC) and isotope internal (IS) standards, nine metabolite standards and the IS were dissolved with 90% acetonitrile to a final concentration of 1 mg/mL.…”
Section: Methodsmentioning
confidence: 99%
“…In addition, first-generation AEDs such as carbamazepine (CBZ), ethosuximide (ESM), phenobarbital (PHB), phenytoin (PHT), primidone (PRM), and valproic acid are still widely used in primary hospital of China or other developing countries. Thus, therapeutic drug monitoring (TDM) is still necessary for the clinical management of patients with epilepsy [13][14][15]. Several techniques are available for TDM of AEDs.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, only a limited number of the newer AEDs are quantifiable by the technique [5,18]. Chromatographybased methods, which can fulfill simultaneous separation, and accurate and sensitive determination of multiple compounds, have been widely implemented in the TDM of AEDs, such as GC coupled with flame ionization [19], electron capture [20], nitrogen-phosphorus [20] or MS detector [21], HPLC or UHPLC coupled with UV-visible (UV-VIS) [22], electrochemical [23], fluorescence [24] or mass spectrometry (MS) detector [13,25], and high-performance CE (HPCE) [26]. Among those methods, for its lower cost and higher applicability for most drugs, HPLC-UV is more suitable than the others for TDM of AEDs in most hospitals, especially primary hospitals in developing countries [18,[27][28][29].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, pharmacokinetic or pharmacodynamics interaction between AEDs and other drugs also is a non-negligible factor that influences drug concentration and therapeutic effect [7][8][9][10]. Therefore, it will be better if therapeutic drug monitoring (TDM) for the clinical management of epileptic patients with second-or third-generation AEDs is performed [11,12]. TDM has been defined as the measurement and clinical use of drug concentration to optimize the patient's outcome, thereby individualizing treatment [12].…”
Section: Introductionmentioning
confidence: 99%